9 Reasons Gallstone Risk Rises Sharply at Menopause and Why Estrogen Therapy Adds a Layer of Complexity
Nobody warned me that a nagging ache under my right ribs could be connected to the same hormonal shift causing my hot flushes. The gallbladder felt like someone else's problem — until it wasn't. This is one of those topics where knowing the physiology ahead of time genuinely changes what you notice and what questions you think to ask.
Learn more about Rose →Estrogen Directly Makes Bile More Lithogenic
Estrogen increases the amount of cholesterol secreted into bile while simultaneously reducing bile acid synthesis, which is the mechanism that normally keeps cholesterol dissolved and flowing. The result is bile that is chemically supersaturated with cholesterol — the precise environment in which cholesterol gallstones form. This effect has been documented in both endogenous estrogen fluctuations and exogenous estrogen use, making the menopause transition itself a period of meaningful biological risk.
Progesterone Slows Gallbladder Emptying
Progesterone reduces the contractility of the gallbladder wall, meaning bile sits in the gallbladder longer than it should instead of being efficiently ejected into the small intestine after meals. The longer bile stagnates, the more opportunity cholesterol crystals have to nucleate and clump into stones — a process called biliary sludge that is the precursor to fully formed gallstones. During perimenopause, progesterone levels are erratic and often elevated in certain cycles, contributing to this stasis effect.
The Estrogen-to-Progesterone Ratio Shift Creates a Window of Vulnerability
Perimenopause is not simply a smooth decline in all hormones — it is characterised by a period during which estrogen can surge erratically while progesterone drops more consistently, creating an estrogen-dominant phase before both hormones eventually fall. This ratio imbalance amplifies the lithogenic bile effect without the counterbalancing progesterone-related emptying that existed during regular cycles. Women in early perimenopause may therefore face a particularly sharp window of elevated gallstone risk before they have even registered significant menopause symptoms.
Body Composition Changes at Midlife Raise Baseline Risk
The shift toward central adiposity that commonly accompanies menopause — driven by declining estrogen and changing insulin sensitivity — is independently associated with higher cholesterol gallstone formation. Adipose tissue, particularly visceral fat, increases hepatic cholesterol synthesis and secretion into bile, compounding the hormonal effect on bile composition. A woman who gains even modest weight around the abdomen during the menopause transition may be facing a combined hormonal and metabolic push toward gallstone formation.
Insulin Resistance Amplifies Cholesterol Secretion Into Bile
Insulin resistance, which becomes more prevalent after menopause due to both estrogen loss and age-related metabolic changes, drives the liver to produce and export more cholesterol — much of which ends up in bile. Higher biliary cholesterol concentration directly increases the likelihood that cholesterol will crystallise rather than stay in solution. This metabolic pathway means that women who develop prediabetes or worsening insulin resistance around menopause are stacking a second risk factor on top of the hormonal one.
Oral HRT Carries a Higher Gallstone Risk Than Transdermal HRT
When estrogen is taken orally, it passes through the liver in its first pass before reaching systemic circulation, and this hepatic exposure significantly amplifies the lithogenic effect on bile composition — increasing biliary cholesterol saturation more than transdermal delivery does. Transdermal estrogen, delivered via patch, gel, or spray, bypasses the liver's first pass and produces a substantially smaller effect on bile chemistry. Multiple observational studies and the large Women's Health Initiative data confirm that oral estrogen users have meaningfully higher rates of gallbladder disease compared to non-users, while the transdermal signal is considerably weaker.
Rapid Weight Loss — Common During Menopause Attempts at Lifestyle Change — Is a Gallstone Trigger
When the body mobilises fat stores quickly, the liver floods bile with cholesterol, and gallbladder motility often decreases simultaneously, creating ideal conditions for stone formation. This is a well-established phenomenon in any population losing weight quickly, but it is particularly relevant at menopause when women frequently attempt significant dietary changes or calorie restriction to counter weight gain. The clinical guidance is not to avoid weight loss but to avoid very rapid loss — more than about 1–1.5 kg per week consistently raises risk.
Reduced Physical Activity Compounds Gallbladder Stasis
Physical movement is a genuine mechanical stimulus for gallbladder contraction and bile flow — sedentary behaviour is consistently associated with higher gallstone prevalence independent of body weight. Many women experience fatigue, joint discomfort, and disrupted sleep during perimenopause that reduce their activity levels, indirectly slowing gallbladder motility further. The gallbladder essentially needs regular prompting to empty completely, and exercise is one of the most reliable ways to provide that stimulus.
Gallstone Symptoms Are Frequently Mistaken for Other Menopause Complaints
Biliary colic — the pain caused by a gallstone temporarily blocking the bile duct — typically presents as a deep, cramping ache in the upper right abdomen or between the shoulder blades, often triggered by fatty meals, and it can last from twenty minutes to several hours before resolving. This pattern is easy to attribute to digestive sensitivity, bloating, or general gastrointestinal upset that many women already experience during hormonal fluctuation. The practical implication is that new or recurring upper abdominal pain in a perimenopausal or postmenopausal woman warrants specific investigation for gallbladder disease rather than a reflexive assumption that it is hormone-related gut dysregulation.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.